Nicolas T Terrigino
4PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.Scott Wilkinson, Anson T Ku, Rosina T Lis
|Mar 01, 2022
Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer.John R Bright, Rosina T Lis, Anson T Ku
|Oct 07, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.Fatima Karzai, Stephanie M Walker, Scott Wilkinson
|Jul 19, 2020
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.Nichelle C Whitlock, Shana Y Trostel, Scott Wilkinson
Pageof 1
Frequent Collaborators
4 joint publications
Scott Wilkinson
4 joint publications
Adam G Sowalsky
3 joint publications
Rosina T Lis
3 joint publications
Nicole V Carrabba
2 joint publications
John R Bright
2 joint publications
Anson T Ku
2 joint publications
Nichelle C Whitlock
2 joint publications
Shana Y Trostel
2 joint publications
Stephanie A Harmon
2 joint publications
Baris Turkbey
